Skip to main content

Table 2 Estimated hazard ratios in the full and reduced multivariable flexible parametric regression models

From: Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study

Predictors

Full model

Reduced model

HR

95% CI

P value

HR

95% CI

P value

Age group (years)

 ≤ 60

1.00

Reference

 

1.00

Reference

 

 > 60

2.13

0.99, 4.54

0.052

1.77

0.97, 3.23

0.062

Karnofskys Performance Status

 Good

1.00

Reference

 

1.00

Reference

 

 Moderate

1.86

0.71, 4.88

0.204

2.00

0.96, 4.18

0.066

 Poor

3.64

1.61, 8.21

0.002

2.96

1.48, 5.92

0.002

Cirrhosis

 No

1.00

Reference

  

Not included

 

 Yes

1.20

0.60, 2.39

0.600

   

Ascites

 No

1.00

Reference

  

Not included

 

 Yes

1.05

0.32, 3.42

0.935

   

Total bilirubin (mg/dL)

 < 2.0

1.00

Reference

 

1.00

Reference

 

 2.0–3.0

3.27

0.20, 12.59

0.085

2.22

0.82, 5.99

0.114

 > 3.0

9.22

2.46, 34.50

0.001

10.44

3.92, 27.82

< 0.001

Serum albumin (mg/dL)

 > 3.5

1.00

Reference

  

Not included

 

 2.8–3.5

0.80

0.34, 1.91

0.619

   

 < 2.8

2.66

1.05, 6.71

0.039

   

Number of primary tumor

 Single tumor

1.00

Reference

 

1.00

Reference

 

 Multiple tumor

3.42

1.23, 9.51

0.019

2.63

1.29, 5.35

0.008

Portal vein involvement

 No

1.00

Reference

  

Not included

 

 Yes

1.46

0.75, 2.85

0.265

   

Visceral organ metastasis

 No

1.00

Reference

  

Not included

 

 Yes

1.19

0.85, 1.67

0.301

   

Number of vertebral columns involved

 1

1.00

Reference

  

Not included

 

 2

1.10

0.52, 2.32

0.807

   

 ≥ 3

1.70

0.69, 4.16

0.248

   

Number of extraspinal bone metastases

 0

1.00

Reference

  

Not included

 

 1–2

0.93

0.31, 2.78

0.892

   

 ≥ 3

1.03

0.33, 3.19

0.964

   
  1. Abbreviations: HR hazard ratio, CI confidence interval